Lactoferrin, a marker for periodontal disease

Current HIV Research

Volumn 11, Issue 3, 2013, Pages 220-225

  Lourenço, Alan G ^a   Nakao, Cristiano ^a   Machado, Alcyone A ^a   Motta, Ana C F ^a   Tonani, Ludmilla ^a   Candido, Regina C ^a   Komesu, Marilena C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HIV AIDS; Lactoferrin; Periodontal disease; Quantification of Candida spp; Saliva

Indexed keywords

LACTOFERRIN;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; SALIVA ANALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CANDIDA; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; PERIODONTAL DISEASES; SALIVA; YOUNG ADULT;

EID: 84880092052     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X11311030006     Document Type: Article

References (21)

1. Freitag C, Chougnet C, Schito M, et al. Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T cell-dependent immune activation. J Infect Dis 2001; 183: 1260-8.
2. González-Chávez AS, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009; 33: 301-8.
3. Kazmi SH, Naglik JR, Sweet SP, et al. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006; 13: 1111-8.
4. Groot F, Geijtenbeek TBH, Sanders RW, et al. Lactoferrin prevents dendritc cell-mediated human deficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J Virol 2005; 79: 3009-15.
5. Pierce A, Legrand D, Mazurier J. La lactoferrine: une protéine multifonctionnelle. Med Sci (Paris) 2009; 25: 361-9.
6. Lourenço AG, Figueiredo LTM. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil. Med Oral Patol Oral Cir Buccal 2008; 13: E281-6.
7. Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations and in HIV infected children. J Clin Pediatr Dent 1999; 23: 85-9.
8. Glimvall P, Wickström C, Jansson H. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis? J Periodontal Res 2012; 47: 655-60.
9. Jentsch H, Sievert Y, Göcke R. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment. J Clin Periodontol 2004; 31: 511-4.
10. Ramseier CA, Kinney JS, Herr AE, et al. Identification of Pathogen and Host-Response Markers Correlated With Periodontal Disease. J Periodontol 2009; 80: 436-46.
11. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986; 15: 386-8.
12. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993; 694: 72-7.
13. Schekels LC, Veerman EC, Amerongen AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med 1995; 6: 161-75.
14. Ozdemir B, Ozcan G, Karaduman B, et al. Lactoferrin in Gingival Crevicular Fluid and Peripheral Blood during Experimental Gingivitis. Eur J Dent 2009; 3: 16-23.
15. Actor JK, Hwang AS, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des 2009; 15: 1956-73.
16. Fine DH, Tofsky N, Nelson EM, Schoen D, Barasch A. Clinical implications of the oral manifestation of HIV infection in children. Dent Clin N Am 2003; 47: 159-74.
17. Coogan MM, Greenspan J, Challacombe SJ. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 2005; 83: 700-6.
18. Mizobe-Ono L, Araújo JLP, Dos-Santos MC. Componentes das imunidades inata e adaptativa presentes na saliva humana. Revista de Odontologia da UNESP 2006; 35: 253-61.
19. Wakabayashi H, Kondo I, Kobayashi T, et al. Periodontitis, periodontopathic bacteria and lactoferrin. Biometals 2010; 23: 419-24.
20. Lin AL, Johnson DA, Patterson TF, et al. Salivary anticandidal activity and saliva composition in an HIV infected cohort. Oral Microbiol Immunol 2001; 1: 270-8.
21. Tanida T, Okamoto T, Okamoto A, et al. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 2003; 32: 586-94.